A to Z
Data &
Forms &
News &
Licensing &
Rules &
Public Health
Print this Article   Bookmark and Share
EIP/HAI Point Prevalence Special Study

The U.S. Centers for Disease Control and Prevention (CDC) launched the Emerging Infections Program (EIP) to develop centers of excellence in infectious disease surveillance and applied public health research in selected state health departments. The Oregon EIP is participating in the study described below.

Prevalence Study - Abstract


EIP/HAI Point Prevalence Evaluation

The Emerging Infections Program (EIP)/Healthcare-Associated Infections (HAI) and Antimicrobial Use Prevalence Survey is a one-day survey of antimicrobial use in up to 250 hospitals at ten different sites across the US including California, Colorado, Connecticut, Georgia, Maryland, Minnesota, New Mexico, New York, Oregon, and Tennessee.

This project is designed to:

  • Estimate the prevalence of HAIs and antimicrobial use among inpatients of acute healthcare facilities
  • Enhance our understanding of how different pathogens are distributed in different HAIs
  • Increase awareness of the reasons why antimicrobials are used in health care facilities

At least seventeen hospitals in the ten-county area surrounding Portland and Eugene will be participating in this study.  Data collection began in May 2011 and the study will be complete in the Summer of 2012.

To see all Oregon Emerging Infections Program special studies go to EIP special studies.